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OBJECTIVES: To determine the characteristics, the frequency and the mortality rates of patients needing
mechanical ventilation and to identify the risk factors associated with mortality in the intensive care unit (ICU)
of a general university hospital in southern Brazil.
METHOD: Prospective cohort study in patients admitted to the ICU who needed mechanical ventilation for at
least 24 hours between March 2004 and April 2007.
RESULTS: A total of 1,115 patients admitted to the ICU needed mechanical ventilation. The mortality rate was
51%. The mean age (± standard deviation) was 57±18 years, and the mean Acute Physiology and Chronic
Health Evaluation II (APACHE II) score was 22.6±8.3. The variables independently associated with mortality
were (i) conditions present at the beginning of mechanical ventilation, age (hazard ratio: 1.01; po0.001); the
APACHE II score (hazard ratio: 1.01; po0.005); acute lung injury/acute respiratory distress syndrome (hazard
ratio: 1.38; p=0.009), sepsis (hazard ratio: 1.33; p=0.003), chronic obstructive pulmonary disease (hazard ratio:
0.58; p=0.042), and pneumonia (hazard ratio: 0.78; p=0.013) as causes of mechanical ventilation; and renal
(hazard ratio: 1.29; p=0.011) and neurological (hazard ratio: 1.25; p=0.024) failure, and (ii) conditions occurring
during the course of mechanical ventilation, acute lung injuri/acute respiratory distress syndrome (hazard ratio:
1.31; po0.010); sepsis (hazard ratio: 1.53; po0.001); and renal (hazard ratio: 1.75; po0.001), cardiovascular
(hazard ratio: 1.32; pp0.009), and hepatic (hazard ratio: 1.67; pp0.001) failure.
CONCLUSIONS: This large cohort study provides a comprehensive profile of mechanical ventilation patients in
South America. The mortality rate of patients who required mechanical ventilation was higher, which may have
been related to the severity of illness of the patients admitted to our ICU. Risk factors for hospital mortality
included conditions present at the start of mechanical ventilation conditions that occurred during mechanical
support.
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’ INTRODUCTION
Acute respiratory failure (ARF) is a common cause of
admission to the intensive care unit (ICU) that occurs for
several reasons, including pulmonary disease, neuromuscu-
lar disease, shock and the need for airway protection or
temporary respiratory support after major surgery. For
patients with ARF, mechanical ventilation (MV) is the
cornerstone of management (1,2). Patients admitted to ICUs
who need MV are expected to have higher mortality rates
compared with those who do not require respiratory support (3).
Despite advances in the management of ARF with MV,
mortality has not decreased significantly and costs remain
high (4-9). Knowledge of the epidemiology of patients
requiring MV, including mortality rates and mortality risk
factors, may help to improve therapeutic strategies, as might
counseling of patients or their relatives (10). Esteban et al.
found that mortality depends on (i) factors present at the start
of MV, (ii) factors developed during the course of MV, and
(iii) factors related to patients’ management (10). Other studiesDOI: 10.6061/clinics/2016(03)05
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have addressed the specific risk factors in such patients,
including multiple organ dysfunction, age, the Simplified
Acute Physiology Score II (SAPS II), nonpulmonary sources of
respiratory failure, and immunosuppression (3, 5,11-13).
Knowledge of the epidemiological profile of patients with
ARF requiring MV in Latin America is scarce, particularly in
Brazil. In particular, Tomicic et al. (14) explored the char-
acteristics and mortality risk factors of 156 patients who
required MV in 19 ICUs in Chile, and Azevedo et al. (15)
evaluated 773 adult patients admitted to 45 ICUs in Brazil
over a two-month period who required MV for more than
24 hours. Further studies are needed to improve the under-
standing of patients who require MV in developing countries
in which there is limited resource allocation. Therefore, our
study aimed to determine the characteristics, the frequency
and the mortality rates of patients who needed MV in
southern Brazil.
’ MATERIALS AND METHODS
Study design
This prospective cohort study was conducted between
March 1st, 2004 and April 30th, 2007, in the ICU of the
Hospital de Clínicas de Porto Alegre, a teaching hospital in
the city of Porto Alegre, in southern Brazil. In Porto Alegre
and its metropolitan area, the estimated population size is
1,436,123 and 4,063,886 inhabitants, respectively.
The ICU has 24 beds and is assisted by one doctor and
nurse assistant for every five patients and by one nurse
technician for every two patients during the day. In addition,
one physiotherapist and one medical resident aid every ten
and two patients, respectively. During the night and on
weekends, one doctor and nurse assistant help every ten
patients, one nurse technician helps every two patients, and
one medical resident helps every ten patients. At the time of
the study, the ICU occupancy rate was 90%.
Data collection
Patients admitted to the ICU who were X18 years old
were included in the study after completing 24 consecutive
hours on either non-invasive MV (NIMV) or invasive MV
(IMV). Patients were excluded if they did not complete
24 hours on MV or did not require it. Each patient was
followed during the course of MV for a period of 28 days or
until death. All information was collected by trained
personnel through a standardized questionnaire.
Study variables
The following information was obtained:
Outcome variables. (i) the overall mortality rate, defined
as the mortality rate of all patients admitted to the ICU during
the period of the study; (ii) the specific mortality rate, defined
as the total number of deaths among MV patients during the
study period; and (iii) the length of stay (LOS) in the ICU and
hospital.
Independent variables. Age; gender; the Acute Physiol-
ogy and Chronic Health Evaluation II (APACHE II) score
obtained within the first 24 hours of admission; patient
status (clinical or surgical); the modality of respiratory
support (NIMV or IMV); the main reason(s) for MV;
tracheostomy; and previous health status, including hepatic,
renal, cardiovascular, neurological, gastrointestinal and hema-
tologic failure (16). Data were collected regarding events that
developed during the MV period, including acute lung injury
(ALI)/acute respiratory distress syndrome (ARDS) (17); baro-
trauma; sepsis; ventilator-acquired pneumonia (VAP) (18);
organ failure (16); weaning failure; and use of drugs such as
sedatives, analgesics, and vasoactive or neuromuscular blockers.
Weaning failure was defined as a need for reintubation and IMV
within the first 48 hours after extubation. Data on arterial blood
gases, chest X-rays, ventilatory parameters and modes of MV
were also recorded.
Statistical analysis
Data analysis was performed considering factors present at
the start and/or occurring over the course of MV. Categorical
variables were coded as dummy variables to compare all cate-
gories with the one having the lower mortality. A univariate
analysis was performed to identify the variables associated with
mortality using either the chi-squared (w2) test (categorical
variables) or Student’s t test (continuous variables). Con-
tinuous variables were also compared using ANOVA and the
post hoc Tukey test. A w2 test for linear trends was used to
relate mortality rates to the number of organ failures.
A Kaplan-Meier analysis was used to determine the prob-
ability of survival during MV. A Cox proportional hazards
model was conducted using the PHREG procedure from SAS
to identify factors independently associated with mortality. In
this analysis, the outcome was defined as the time, in days,
between the beginning of MV and death. The criteria for
variables entering the multivariable model was po0.25 in the
univariable models and/or clinical relevance. Variables were
excluded from the model one at a time, keeping those
significant at 5% in the final model. The statistical analysis
was performed using SPSSs version 18.0 and SASs version
9.2. The analysis was reviewed by a consultant with formal
statistical training and experience. His analysis was performed
after all data collection and after the analysis had been
independently carried out by another investigator.
Ethics
The study was approved by the hospital’s research ethics
committee (number: 03-502) with an informed consent waiver.
The research team also signed an institutional document
ensuring full confidentiality of the patients’ records.
’ RESULTS
A total of 2,430 patients were admitted to the ICU during
the study period, and 1,115 (46%) were included in the study.
Table 1 describes the characteristics of the studied population.
The most common reasons for initiation of MV were sepsis
(41.8%), shock (37.8%), pneumonia (37%) and ALI/ARDS
(15%). The frequency of IMV was 97.7%, which included
patients who started on this mode of ventilation at the
beginning of the study (92.6%) and those who failed NIMV
(5.1%). The rate of weaning failure for IMV was 29.4%.
Regarding NIMV, 7.4% (n=83) patients initiated this mode
of ventilatory support, but only 2.3% (n=26) remained on
NIMV during the entire course of MV. Therefore, the failure
rate of NIMV was 68.7%. The major reasons for the use of
NIMV were pneumonia (49%; n=41), sepsis (31%; n=26),
ALI/ARDS (17%; n=14), and chronic obstructive pulmonary
disease (COPD) (15%; n=13). The rate of NIMV failure was
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79% in ALI/ARDS, 61.5% in pneumonia, 73% in sepsis, and
38.5% in COPD. Additionally, 10.4% of the patients needed
tracheostomy and 70.1% (782/1115) needed vasopressors.
The ventilator modes and the monitored respiratory
variables on days 1, 2 and 3 (mean values) of IMV in all
patients as well as in the COPD and ARDS groups in
particular are presented in Table 2. Assisted/controlled
pressure ventilation was the most commonly used mode of
IMV in all groups. Table 3 describes the outcomes among the
COPD, ARDS and other patient (non-COPD and non-ARDS)
groups. Patients with ARDS presented a longer duration of
IMV compared with those with COPD and other patients
(12.1±8.7 vs. 8.9±5.5 and 9.3±7.3, p=0.01). The LOS values
in the ICU and hospital were similar among groups.
The overall and the specific mortality rates of MV patients
were 23% (564/2430) and 51% (564/1115), respectively.
Regarding COPD patients in particular, the mortality rate
was 26.7% (16/60). In ARDS patients, the mortality rate was
66% (204/307). The mortality rate in patients who developed
ARDS during MV (71%; 126/180) was higher, but not
significantly different (p=0.15), compared with the rate in
those with ARDS as the cause of MV (63%; 78/127). Figure 1
presents the survival curves for the ARDS and COPD groups
and also for the other studied patients (po0.001).
The main events that occurred during MV were sepsis
(n=210; 18.8%), VAP (n=181; 16%), ARDS (n=180; 16%), and
barotrauma (n=32; 2.8%). The mortality rates are shown in
Table 4; these rates increased as the number of failing organs
increased. There was a high percentage of patients with
failure of three or more organs in the cohort (45%), especially
among patients with ARDS (52%) and in COPD patients
(15%). In addition, patients developed the following types of
organ failure during the course of MV: renal (n=290; 26%),
cardiovascular (n=227; 20.4%), coagulopathic (n=201; 18%),
neurological (n=115; 10%) and hepatic (n=86; 7.7%).
The factors independently associated with hospital mor-
tality are illustrated in Table 5. The conditions present at the
beginning of MV were age; the APACHE II score; renal and
neurological failure; and, as causes of MV, ALI/ARDS and
sepsis. The conditions occurring over the course of MV were
ALI/ARDS; sepsis; and renal, cardiovascular, and hepatic
failure. The following variables were negatively associated
with mortality: COPD exacerbation and pneumonia as
causes of MV, in addition to VAP.
’ DISCUSSION
The main findings of our study were as follows: (i) the
hospital mortality rate of patients who required MV was 51%
and (ii) the factors associated with increased mortality
included conditions present at the start of MV as well as
conditions that occurred during mechanical support.
The frequency of MV in our study was in agreement with
frequencies described in other publications (3,11). Carson
et al. showed that the incidence of MV increased by 11% over
7 years, with a higher burden of comorbidities and fewer
Table 1 - Characteristics of the Studied Patients on Admission to
the Intensive Care Unit.
Characteristic Number of Patients
Mechanically Ventilated
Age, median±SD 57.2±18
Gender, males 582 (52%)
APACHE II score, mean±SD 22.6±8.3
Medical/Surgical 771 (69%)/344 (31%)
Source of admission
Hospital ward 625 (56%)
Emergency department 278 (25%)
Other hospitals 212 (19%)
Reason for the initiation of
mechanical ventilation1
Sepsis 466 (41.8%)
Shock 421 (37.8%)
Pneumonia 415 (37%)
ALI 167 (15%)
ALI without ARDS 40 (3.6%)
ARDS 127 (11.4%)
Neurological condition
Stroke 79 (7.1%)
Neuromuscular disease 15 (1.3%)
Other neurological condition 32 (3%)
COPD 60 (5.4%)
Cardiac arrest 67 (6.0%)
Asthma 16 (1.6%)
Other 14 (1.2%)
APACHE II = Acute Physiology and Chronic Health Evaluation II;
ALI = acute lung injury; ARDS = acute respiratory distress syndrome;
COPD = chronic obstructive pulmonary disease; SD = standard deviation;
1 more than one reason for initiation of mechanical ventilation was
allowed.
Table 2 - Ventilator Modes and Monitored Variables on Days 1, 2 and 3 (Mean Values) of Invasive Mechanical Ventilation.
Overall (n=976)1 COPD (n=56)a ARDS (n=263)a
Ventilator mode, no. (%)
ACP 715 (73) 37 (66) 200 (76)
PSV 195 (20) 14 (25) 46 (17.5)
CPAP 29 (3) 3 (5) 9 (3.5)
ACV 22 (2.5) 2 (4) 7 (2.5)
SIMV 15 (1.5) 0 (0) 7 (2.5)
Monitored variable, mean±SD
Peak pressure, cm H2O 25.5±8.1 24±4.8 28.5±8.2
Plateau pressure, cm H2O 21.5±5.8 20.2±4.6 23.6±6.4
Tidal volume, ml/kg (PBW) 10.5±3.3 10±3 9±3.3
Respiratory rate, breaths/min 20.1±4.1 19.3±3.8 21.2±4.4
PaO2/FiO2 298.8±155 292.4±118 169±111.3
PEEP, cm H2O 6.6±2.5 5.8±1.5 9±4
COPD = chronic obstructive pulmonary disease; ARDS = acute respiratory distress syndrome; ACP = assisted/controlled pressure ventilation; ACV = assisted/
controlled volume ventilation; PSV = pressure support ventilation; CPAP = continuous positive airway pressure; SIMV = synchronized intermittent
mandatory ventilation; PBW = predicted body weight; PEEP = positive end-expiratory pressure; SD = standard deviation; 1 the percentages of missing data
for all patients and for the COPD and ARDS groups in particular were 12%, 11%, and 14%, respectively; 2 refers to non-COPD and non-ARDS patients.
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discharges to home (8). Additionally, assisted/controlled
pressure ventilation was the most commonly used mode of
IMV in all groups in the current study and this observation
was similar to the results of another study (10).
The rate of mortality in the present study was higher than
rates in several multicenter prospective cohort studies, which
ranged from 30.7-42% (5,8,10,11,14,15,19). In one Brazilian
multicenter study by Azevedo et al., the hospital mortality
rate was 42% (15). When comparing the mortality rates in
our study with those in the literature, several aspects must be
taken into account. These aspects include different meth-
odologies (e.g., inclusion criteria, characteristics of the
population) and different severities of illness. Our study
specifically showed that APACHE II score, organ failures,
ALI/ARDS, sepsis and age were independently associated
with hospital mortality. Mortality risk factors have also been
the focus of several investigations (3,5,8,10,11,13-15). The
high severity of illness in our cohort may have contributed to
the elevated mortality rates. In this study, the mean APACHE
II score was higher when compared with scores in other
studies (5,14). Studies have also evaluated the severity of
illness using the SAPS II score, which is difficult to compare
across studies (10,11,15). Further evidence that our popula-
tion had more severe illness was the higher percentage of
patients with failure of three or more organs (45%) compared
with the percentage in another study, in which 13% of the
patients had this condition (13). Other reasons for higher
mortality in our study were the reasons for initiation of MV,
which included sepsis (41.8%), shock (37.8%), pneumonia
(37%) and ALI/ARDS (15%). Azevedo et al. showed that the
main causes included pneumonia (27%), neurological failure
(19%) and non-pulmonary sepsis (12%) (15). In addition,
Esteban et al. reported different percentages for the main
causes of MV, such as postoperative patients (10). Taken
together, these disparities probably resulted in a less severely
ill population with lower mortality rates (10,15).
Table 3 - Duration of Mechanical Ventilation and Length of Stay in the Intensive Care Unit and in the Hospital in the Studied Patients.
Other Patients2 (n=748) COPD (n=60) ARDS (n=307) p-value*
Duration of MV1 9.3±7.3 8.9±5.5 12.1±8.7 o0.01**
LOS in ICU1 14.6±11.5 14.3±10 15.6±11.6 0.19
LOS in hospital1 24.7±22.9 24.3±18.1 22.3±21 0.12
MV = mechanical ventilation; LOS = length of stay; COPD = chronic obstructive pulmonary disease; ARDS = acute respiratory distress syndrome;
1 days; 2 refers to non-COPD and non-ARDS patients; *p-value for ANOVA; **po0.001 for ANOVA (and po0.05 for the Tukey test for the following
comparisons: COPD vs. ARDS patients and other patients vs. ARDS patients).
Figure 1 - Kaplan-Meier curves of the probability of survival over time for mechanical ventilation.
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The mortality of ARDS patients observed in our study was
high. One reason for this high mortality rate in ARDS
patients was the severity of illness, with a mean APACHE II
score of 23.6. Furthermore, 42.5% of ARDS patients had
failure of three or more organs. Additionally, in ARDS
patients, the tidal volumes were higher than those suggested
in the context of a lung-protective strategy, which reduces
mortality in these patients (20). During the period of our
study, a lung-protective strategy was not completely
incorporated into our practice, which also could have
affected the mortality rate. Another reason for discrepancy
could be that in our study, we used a previously established
criterion for the classification of ALI/ARDS (17), whereas
mortality rates in other studies may have been influenced by
the recent new Berlin definition of this syndrome (21).
In Brazil in particular, using the Berlin definition, Azevedo
et al. reported a hospital mortality rate of 52% (15).
A systematic review found that ARDS mortality has
remained static, at 44%, for observational studies since the
1994 consensus definition of this syndrome (22,23). For
example, in the ALIEN study, the hospital mortality rate
was 47.8% (24). In the setting of low-to-middle countries,
best-practices strategies should be employed to reduce the
mortality rates in ARDS patients.
Our finding that age was independently associated with
mortality in MV patients has also been described in previous
studies (8). In our study, COPD and pneumonia as causes of
MV, in addition to VAP, were found to be negatively
associated with mortality in these patients. COPD was also
found to be protective by Esteban et al. (10). One possible
explanation for the negative association of COPD and
hospital mortality in the present study may be that such
patients were less severely ill than those without COPD
were; these patients presented fewer morbidities during the
MV period (nonrespiratory system dysfunction). It should be
noted that few patients had COPD exacerbation as a cause of
MV and admission to the ICU in this study. Pneumonia as a
cause of MV was also found to be negatively related to
mortality, which may have been due to a lower percentage of
failure of three or more organs in this group of patients.
In two studies that examined risk factors for needing
ventilatory support, pneumonia was not associated with
mortality after the multivariate analysis (6,10). Studies of
fatality rates comparing patients with and without VAP have
Table 5 - Statistical Analysis of the Factors Associated with Mortality in Mechanical Ventilation Patients.
Variable Univariable Multivariable
HR (95% CI)* p-value** HR (95% CI)* p-value**
Age (years) 1.07 (1.002-1.012) 0.004 1.01 (1.004-1.014) o0.001
APACHE II score 1.01 (1.007-1.02) o0.0001 1.01 (1.002-1.014) o0.005
Chronic use of corticosteroids 0.72 (0.53-0.97) 0.03
Failure previous to MV
Cardiovascular 1.42 (1.20-1.67) o0.0001
Coagulopathic 1.46 (1.21-1.77) o0.0001
Hepatic 1.26 (1.02-1.57) 0.03
Renal 1.34 (1.14-1.59) 0.0005 1.29 (1.06-1.56) 0.011
Neurological 1.13 (0.94-1.35) 0.17 1.25 (1.031.52) 0.024
Cause of MV initiation
COPD 0.42 (0.25-0.69) 0.0006 0.58 (0.35-0.98) 0.042
ALI/ARDS 1.33 (1.08-1.65) 0.008 1.38 (1.08-1.77) 0.009
Sepsis 1.47 (1.25-1.73) o0.0001 1.33 (1.10-1.61) 0.003
Pneumonia 0.88 (0.74-1.05) 0.15 0.78 (0.65-0.95) 0.013
Asthma 0.43 (0.16-1.15) 0.09
Condition occurring during MV
Sepsis 1.48 (1.22-1.79) o0.0001 1.53 (1.23-1.90) o0.001
VAP 0.70 (0.53-0.91) 0.009 0.62 (0.46-0.83) 0.001
ALI/ARDS 1.42 (1.19-1.71) 0.0001 1.31 (1.07-1.61) o0.010
Failure
Cardiovascular 1.54 (1.28-1.85) o0.0001 1.32 (1.07-1.62) p0.009
Coagulopathic 1.41 (1.16-1.72) 0.0006
Hepatic 1.91 (1.48-2.48) o0.0001 1.67 (1.26-2.21) p0.001
Renal 1.86 (1.57-2.22) o0.0001 1.75 (1.42-2.15) o0.001
ALI/ARDS = acute lung injury/acute respiratory distress syndrome; APACHE II = Acute Physiology and Chronic Health Evaluation II; COPD = chronic
obstructive pulmonary disease; MV = mechanical ventilation; VAP= ventilator-associated pneumonia; * hazard ratio (HR) and 95% confidence
interval (CI) for the HR; ** p-value for the analysis. In the final multivariate model, variables with p40.05 were not included.
Table 4 - Severity of Illness and Hospital Mortality According to the Number of Organs with Failure.
Group n Age* APACHE II Score* Hospital Mortality (%)** HR (95% CI)**
ARF+0 138 57.5±17.8 19.0±7.2 21.0% 1.0
ARF+1 248 57.1±19.2 19.9±7.4 37.1% 1.91 (1.26-2.89)
ARF+2 285 58.7±17.3 22.7±7.6 54.4% 3.35 (2.26-4.99)
ARF+3 249 58.5±17.3 24.9±8.4 64.7% 4.19 (2.82-6.23)
ARF+4 139 54.0±17.5 26.6±9.2 69.8% 4.62 (3.05-6.99)
ARF+5 56 52.4±19.9 25.3±7.3 73.2% 5.24 (3.25-8.43)
APACHE II = Acute Physiology and Chronic Health Evaluation II; ARF = acute respiratory failure; HR = hazard ratio; CI = confidence interval; *mean±standard
deviation; **p-value for linear trend: hospital mortality (po0.001) and HR (po0.001).
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generated contradictory results as to whether this condition
increases mortality (10,25-27). It should be noted that the
present study was not designed to examine only VAP
patients, but rather included a myriad of patients requiring
MV. In addition, according to our analysis, VAP patients had
a lower percentage of organ failure and of sepsis as a cause of
MV compared with patients without VAP.
Our study showed a lower frequency of NIMV compared
with IMV. Only 2.3% of patients remained on NIMV during
the entire course of MV, which could be explained by our
overwhelming patient demand for the ICU; in fact, many
patients who needed NIMV remained in the emergency
department or in the hospital ward. Our percentage of NIMV
use was lower compared with percentages in other studies
(15,19,28,29). For example, a recent Brazilian study had
higher percentage of NIMV patients, which could have led to
different outcomes (15). Additionally, the percentage of
NIMV failure was higher in our study than in recent
investigations (15,19,29), which may have been related to
the difference in the severity of illness of the patients between
the studies. More specifically, there was an important
difference in the main reasons for the use of NIMV. Our
study also found a higher percentage of patients with
pneumonia, sepsis and ALI/ARDS and a small number of
patients with a greater demonstrated benefit regarding
COPD exacerbation and acute pulmonary edema (29-31).
The percentage of weaning failure in the present study was
higher (29.4%) compared with percentages in the literature
(5-20%) (15,32). Possible reasons may be related to (i) the fact
that certain patients at high risk of weaning failure could not
have used NIMV immediately after extubation and (ii) the
lack of a weaning protocol. Although recognizing that a
protocol would not necessarily be crucial, we think that it
could have helped, considering that our ICU is a multi-
disciplinary unit with a heterogeneous patient population.
Within the last few years, we have been using a weaning
protocol including NIMV in high-risk patients, sharper
surveillance regarding sedation, and physiotherapist partici-
pation in patients’ weaning process. Indeed, recent data have
shown that our percentage of weaning failure has dropped to
21% (32).
The limitations of our study include that (i) the data were
obtained from one ICU, so the results may not be general-
izable to other patients who require MV; (ii) the ICU was at a
tertiary university hospital that admits patients with more
severe illness/conditions, so the interpretation of the results
may be different from that in other studies whose patients
did not have similar disease severity; and (iii) comorbidities,
such as neoplasia, AIDS, cirrhosis, and chronic renal failure,
were not studied, so the influence of such conditions on the
mortality rates of the studied population could not be
estimated. Taking into account these limitations, to the best
of our knowledge, this large study best describes the factors
associated with mortality in ICU patients who required MV.
The hospital mortality rate of MV patients in our study was
higher than rates reported in the literature, which may have
been related to the severity of illness of the studied population.
Furthermore, the factors associated with increased mortality
included conditions present at the beginning of MV as well
as conditions that occurred during mechanical support.
The epidemiological aspects of MV patients explored in our
investigation could enhance knowledge of such patients
in South America. To the best of our knowledge, this large
cohort study of MV patients on this continent may contribute to
a more global understanding regarding the use of MV.
In developing countries such as Brazil in particular, the limited
availability of ICU beds results in the admission of patients
with more severe illness, which may account for the higher
mortality rates. These observations should be considered when
comparing the mortality of such patients among countries
under diverse socioeconomic conditions.
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